Involvement of epithelial to mesenchymal transition in the development of pancreatic ductal adenocarcinoma (Q38248759)

1 September 2017

1 reference

title

Involvement of epithelial to mesenchymal transition in the development of pancreatic ductal adenocarcinoma (English)

1 reference

1 September 2017

1 reference

Kennichi Satoh

1

1 reference

PubMed ID

25216997

1 September 2017

Shin Hamada

series ordinal

2

1 reference

PubMed ID

25216997

1 September 2017

Tooru Shimosegawa

series ordinal

3

1 reference

1 September 2017

14 September 2014

1 reference

Journal of Gastroenterology

1 September 2017

1 reference

1 September 2017

50

1 reference

1 September 2017

2

1 reference

1 September 2017

140-146

1 reference

Cancer incidence and incidence rates in Japan in 2008: a study of 25 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project

1 September 2017

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0997-0

An overview of epithelio-mesenchymal transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0997-0

Epithelial-mesenchymal transitions in development and pathologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0997-0

Epithelial-mesenchymal transitions in tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0997-0

Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0997-0

Molecular requirements for epithelial-mesenchymal transition during tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0997-0

The epithelial-mesenchymal transition generates cells with properties of stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0997-0

Pancreatic cancer: understanding and overcoming chemoresistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0997-0

Vascular endothelial growth factor receptor-1 activation mediates epithelial to mesenchymal transition in human pancreatic carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0997-0

Vascular endothelial growth factor receptor-1 promotes migration and invasion in pancreatic carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0997-0

Bone morphogenetic protein 4 induces epithelial-mesenchymal transition through MSX2 induction on pancreatic cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0997-0

Upregulation of Wnt5a promotes epithelial-to-mesenchymal transition and metastasis of pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0997-0

Macrophage migration inhibitory factor induces epithelial to mesenchymal transition, enhances tumor aggressiveness and predicts clinical outcome in resected pancreatic ductal adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0997-0

Up-regulation of MSX2 enhances the malignant phenotype and is associated with twist 1 expression in human pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0997-0

Zinc transporter LIVI controls epithelial-mesenchymal transition in zebrafish gastrula organizer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0997-0

Regulation of tight junctions during the epithelium-mesenchyme transition: direct repression of the gene expression of claudins/occludin by Snail

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0997-0

E-cadherin regulates metastasis of pancreatic cancer in vivo and is suppressed by a SNAIL/HDAC1/HDAC2 repressor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0997-0

Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0997-0

Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0997-0

Development and characterization of gemcitabine-resistant pancreatic tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0997-0

Acquisition of epithelial-mesenchymal transition phenotype of gemcitabine-resistant pancreatic cancer cells is linked with activation of the notch signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0997-0

Notch signaling activated by replication stress-induced expression of midkine drives epithelial-mesenchymal transition and chemoresistance in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0997-0

The homeobox gene MSX2 determines chemosensitivity of pancreatic cancer cells via the regulation of transporter gene ABCG2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0997-0

Caveolin-1 promotes pancreatic cancer cell differentiation and restores membranous E-cadherin via suppression of the epithelial-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0997-0

Stem cells, cancer, and cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0997-0

The cancer stem cell: premises, promises and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0997-0

Cancer stem cells: current status and evolving complexities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0997-0

Identification of pancreatic cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0997-0

Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0997-0

ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0997-0

Pancreatic cancer stem cells: emerging target for designing novel therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0997-0

Notch-1 induces epithelial-mesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0997-0

Over-expression of FoxM1 leads to epithelial-mesenchymal transition and cancer stem cell phenotype in pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0997-0

Tumour stem cells and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0997-0

Critical appraisal of the side population assay in stem cell and cancer stem cell research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0997-0

Snail contributes to the maintenance of stem cell-like phenotype cells in human pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0997-0

Hypoxia induces EMT in low and highly aggressive pancreatic tumor cells but only cells with cancer stem cell characteristics acquire pronounced migratory potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0997-0

MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0997-0

Genome-wide CpG island profiling of intraductal papillary mucinous neoplasms of the pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0997-0

The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0997-0

Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0997-0

MiR-126 acts as a tumor suppressor in pancreatic cancer cells via the regulation of ADAM9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0997-0

miR-197 induces epithelial-mesenchymal transition in pancreatic cancer cells by targeting p120 catenin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0997-0

miR-655 Is an EMT-suppressive microRNA targeting ZEB1 and TGFBR2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0997-0

Transforming growth factor beta1 treatment leads to an epithelial-mesenchymal transdifferentiation of pancreatic cancer cells requiring extracellular signal-regulated kinase 2 activation

21 January 2018

1 reference

12 December 2020

c-Met is a marker of pancreatic cancer stem cells and therapeutic target

1 reference

12 December 2020

Molecular signatures of pancreatic cancer

1 reference

12 December 2020

microRNA-10b enhances pancreatic cancer cell invasion by suppressing TIP30 expression and promoting EGF and TGF-β actions

1 reference

12 December 2020

Emerging targets in pancreatic cancer: epithelial-mesenchymal transition and cancer stem cells

1 reference

12 December 2020

LIV-1 enhances the aggressive phenotype through the induction of epithelial to mesenchymal transition in human pancreatic carcinoma cells.

1 reference

12 December 2020

10.1007/S00535-014-0997-0

Identifiers

DOI

1 reference

1 September 2017

1 reference

PubMed ID

25216997